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Leiopelmatidaenuran species belonging to the families Bufonidae, Eleutherodactylidae, Hylidae,
Leiopelmatidae, Ranidae, and Scaphiopodidae but antimicrobial peptides have been identiﬁed only in skin
secretions and/or skin extracts of frogs belonging to the Leiopelmatidae (“tailed frogs”) and Ranidae (“true
frogs”). Eight structurally-related cationic α-helical peptides with broad-spectrum antibacterial activity,
termed ascaphins, have been isolated from specimens of Ascaphus truei (Leiopelmatidae) occupying a coastal
range. Characterization of orthologous antimicrobial peptides from Ascaphus specimens occupying an inland
range supports the proposal that this population should be regarded as a separate species A. montanus.
Ascaphin-8 shows potential for development into a therapeutically valuable anti-infective agent. Peptides
belonging to the brevinin-1, esculentin-1, esculentin-2, palustrin-1, palustrin-2, ranacyclin, ranatuerin-1,
ranatuerin-2, and temporin families have been isolated from North American ranids. It is proposed that
“ranalexins” represent brevinin-1 peptides that have undergone a four amino acid residue internal deletion.
Current taxonomic recommendations divide North American frogs from the family Ranidae into two genera:
Lithobates and Rana. Cladistic analysis based upon the amino acid sequences of the brevinin-1 peptides
provides strong support for this assignment.
© 2008 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1556
2. Taxonomy of North American frogs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1557
3. Antimicrobial peptides from North American frogs of the Leiopelmatidae family . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1558
4. Antimicrobial peptides from North American frogs of the Ranidae family. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1558
4.1. Distribution and molecular heterogeneity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1558
4.2. Brevinin-1 peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1559
4.3. Ranatuerin-2 peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1560
4.4. Temporin peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1561
4.5. Ranacyclin-related peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1562
4.6. Brevinin-2-related peptides. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1562
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1563
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15631. Introduction
The skin secretions of many, although by no means all, anurans
(frogs and toads) contain peptides with antibacterial and antifungal
activity. These peptides are stored in granular glands, located mainly
in the skin of the dorsal region, that are surrounded by myocytes and971 3 7672033.
ll rights reserved.innervated by sympathetic ﬁbers. Adrenergic stimulation of the
myocytes in response to stress causes compression of the peptide-
containing serous cells and discharge of their contents by a holocrine-
like mechanism [1]. There are no conserved structural motifs
responsible for activity but the vast majority of the frog skin antimi-
crobial peptides are cationic due to the presence of multiple lysine
residues and have the propensity to adopt an amphipathic α-helical
conformation in the environment of a phospholipid vesicle or in a
membrane-mimetic solvent, such as 50% triﬂuoroethanol–water [2].
Table 1
Distribution of antimicrobial peptides in the skins of North American species of the
genera Rana and Lithobates
Original name Reclassiﬁed Antimicrobial peptides
R. aurora stet Brevinin-1 (2), Ranatuerin-2 (1), Temporin (1)
R. boylii stet Brevinin-1 (3), Ranatuerin-2 (2), Temporin (1)
R. cascadae stet Brevinin-1 (1), Ranatuerin-2 (1), Temporin (4)
R. draytonii stet Brevinin-1 (4), Ranatuerin-2 (2), Temporin (3)
R. luteiventris stet Brevinin-1 (2), Ranatuerin-2 (2), Temporin (3)
R. muscosa stet Ranatuerin-2 (2), Temporin (1)
R. aerolata L. aerolatus Brevinin-1 (1), Esculentin-1 (3), Palustrin-2 (1)
Ranacyclin (2), Ranatuerin-2 (2), Temporin (1)
R. berlandieri L. berlandieri Brevinin-1 (6), Esculentin-2, Ranatuerin-2 (1)
R. catesbeiana L. catesbeianus Brevinin-1 (2), Ranatuerin-1 (1) Ranatuerin-2 (3)
Temporin (5)
R. clamitans L. clamitans Brevinin-1 (2), Ranatuerin-1 (1) Ranatuerin-2 (2),
Temporin (5)
R. grylio L. grylio Brevinin-1 (1), Ranatuerin-1 (2) Ranatuerin-2 (1)
Temporin (4)
R. heckscheri L. heckscheri Brevinin-1 (1), Ranatuerin-2 (1), Temporin (1)
R. okaloosae L. okaloosae Brevinin-1 (1), Palustrin-2 (1), Ranatuerin-2 (1)
Temporin (2)
R. palustris L palustris Brevinin-1 (3), Esculentin-1 (3), Esculentin-2 (1)
Palustrin-1 (4), Palustrin-2 (3), Ranacyclin (3)
Ranatuerin-2 (6), Temporin (1)
R. pipiens L. pipiens Brevinin-1 (4), Esculentin-2 (1), Ranatuerin-2 (1)
Ranacyclin (1), Temporin (1)
R. septentrionalis L.
septentrionalis
Brevinin-1 (4), Brevinin-2-related (1)
Ranatuerin-2 (2) Temporin (3)
R. sevosa L. sevosus Brevinin-1 (1), Esculentin-1 (2), Esculentin-2 (1)




R. sylvatica L. sylvaticus Brevinin-1 (1)
R. tarahumarae L. tarahumarae Brevinin-1 (3) Ranatuerin-2 (3)
R. virgatipes L. virgatipes Brevinin-1 (1), Brevinin-2-related (2),
Ranatuerin-2 (3) Temporin (3)
The values in parentheses show the number of paralogs identiﬁed in each species. The
term stet means no change in the species name.
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vitro against a range of pathogenic microorganisms, includingmany of
those that the animal might be expected to encounter in the wild [3],
so that it is reasonable to propose that they represent a component of
the system of innate immunity that constitutes the ﬁrst line of host
defense for both vertebrate and invertebrate species [4]. However, the
importance of the peptides in the survival strategy of the animal and
the extent to which their production provides an evolutionary
advantage to the species are not clearly understood. At this time,
antimicrobial peptides have been identiﬁed in the skins of frogs from
species belonging to the Bombinatoridae, Hylidae, Hyperoliidae,
Leiopelmatidae, Leptodactylidae, Myobatrachidae, Pipidae, and Rani-
dae families but several well studied species from the Bufonidae,
Ceratophryidae, Dicroglossidae, Microhylidae, Pelobatidae, Pyxice-
phalidae, Rhacophoridae, and Scaphiopodidae families do not appear
to synthesize these peptides [5].
Among those families of anurans found in North America,
representatives of the Leiopelmatidae (“tailed frogs”) and Ranidae
(“true frogs”) have been shown to release a diverse array of
antimicrobial peptides into their skin secretions. Such peptides have
not been detected in skin secretions and/or extracts of those species
studied belonging to the Bufonidae, Eleutherodactylidae, Hylidae
(subfamily Hylinae), and Scaphiopodidae families [5]. There does not
appear to be any obvious correlation between the preferred habitat of
the organism and its ability or inability to synthesize dermal
antimicrobial peptides. Interpretation of these observations is uncer-
tain but it implies that the synthesis of antimicrobial peptides in the
skinmay confer advantage to a particular species but is not essential to
survival of the organism. This review will describe the structural and
biological characteristics of cytolytic peptides found in skin secretions
belonging to species from three genera: Ascaphus (Leiopelmatidae),
Lithobates (Ranidae), and Rana (Ranidae). The distribution and
properties of antimicrobial peptides from frogs of the family Ranidae
were the subject of a comprehensive review published in 2004 [6] and
so this article will focus on data relating to North American species
that have appeared since this time.
2. Taxonomy of North American frogs
The application in recent years of molecular techniques of
phylogenetic analysis, particularly comparisons of nucleotide
sequences of orthologous genes, has led to quite drastic reappraisals
of taxonomic classiﬁcations and evolutionary histories of the anurans
[7]. Many previously well accepted phylogenetic relationships based
upon “classical” criteria, such as morphological characteristics and the
fossil record, are being substantially revised. The situation with
respect to our understanding of the evolutionary history and
phylogenetic relationships of North American frogs is currently in a
state of ﬂux [8]. This article follows the taxonomic recommen-
dations and species names proposed in Amphibian Species of the
World: an Online Reference. Version 5.2. Electronic Database
accessible at http://research.amnh.org/herpetology/amphibia/
index.php. American Museum of Natural History, New York, USA [9].
Nomenclature adopted for antimicrobial peptides from frogs of the
Ranidae family follows recent guidelines [10].
The tailed frog Ascaphus sp. Stejneger, 1899 occupies a uniquely
important position in amphibian phylogeny as the most primitive
extant anuran [11]. Originally classiﬁed alone in the family Ascaphidae
as the sister group to the clade of all other living frogs, it is now
united with the New Zealand frogs of the genus Leiopelma Fitzinger
1861 in the family Leiopelmatidae [9]. Tailed frogs of the genus
Ascaphus occupy two distinct ranges in the northwest region of North
America — the Cascade Mountains and coastal region from British
Columbia south to Northern California, and an inland range in the
northern Rocky Mountains and the Blue and Wallowa mountains. The
ranges are well separated by a zone of reduced rainfall. Althoughtraditionally regarded as a single species, the coastal and inland
groups may be distinguished on the basis of morphological characters
[12] and, more recently by analysis of nucleotide sequences of
mitochondrial cytochrome b and NADH dehydrogenase genes
[13,14]. It has been suggested that divergence of the two groups is
relatively ancient occurring in response to the rise of Cascade
Mountains during the late Miocene (approximately 10 million years
ago). The existence of two well differentiated populations has led to
the proposal that animals from the inland range should be regarded as
a separate species, the Rocky Mountain tailed frog A. montanus [13].
Traditionally, the genus Rana comprised at least 250 species but
subsequent analyses based uponmolecular criteria demonstrated that
this assemblage did not constitute a monophyletic group [7]. Current
taxonomic recommendations have divided the Ranidae into 17 genera
[9]. Those North American ranids formerly classiﬁed in the Amerana
species group (comprising R. aurora, R. boylii, R. draytonii, R.
luteiventris, R. muscosa, and R. pretiosa) are retained in the genus
Rana, which is now restricted to 44 species from Eurasia and North
America. The North American bullfrogs formerly classiﬁed in the
Aquarana species group (comprising R. catesbeiana, R. clamitans, R.
grylio, R. heckscheri, R. okaloosae, R. septentrionalis, and L. virgatipes)
are now united with those in the Pantherana species group, that
includes R. aerolata, R. berlandieri, R. palustris, R. pipiens, R. sevosa, R.
sphenocephala, R. sylvatica, and R. tarahumarae, in the genus Litho-
bates. This taxon currently comprises 49 species from North, Central
and South America to southern Brazil. Table 1 summarizes the
currently accepted species names of frogs from which antimicrobial
peptides have been isolated that were previously classiﬁed in the
genus Rana. It should be pointed out that this division of North
American ranids into the two genera Rana and Lithobates has been
subject to criticism [15].
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A comparison of the primary structures of the antimicrobial
peptides from specimens of Ascaphus from the coastal and inland
ranges supports the assertion that the two populations of the tailed
frog should be recognized as a distinct species [13,20]. Eight peptides
with broad-spectrum antimicrobial activity, termed ascaphin 1–8,
were isolated from norepinephrine-stimulated skin secretions of A.
truei (coastal range) [16]. As shown in Fig. 1, the peptides are
structurally similar to each other, suggesting an origin that involves
multiple duplications of an ancestral gene [17], but they do not
resemble closely any antimicrobial peptide isolated from the skins of
other frog species. The ascaphins do, however, display limited
sequence similarity with the cationic, amphipathic α-helical peptides
pandinin 1 [18] and opistoporin 1[19] isolated from the venoms of
African scorpions but this may be fortuitous rather than indicating an
evolutionary relationship. Ascaphin-1, -3, -5, -7 isolated from tailed
frogs from the inland range (designated M in Fig. 1) show differences
in amino acid compared with the corresponding peptides from A. truei
thereby supporting the assignment of this population to the separate
species A. montanus [19]. Orthologs of ascaphin-2, -6 and -8 were not
detected in the secretions from the inland range frogs.
Ascaphin-8 shows possibilities for development into a therapeuti-
cally valuable anti-infective agent. Circular dichroism (CD) spectra
demonstrate that the peptide adopts an amphipathic α-helical
conformation in a membrane-mimetic solvent such as 50% triﬂuo-
roethanol–water [20]. Ascaphin-8 inhibits with relatively high potency
(minimum inhibitory concentrationMIC≤25 μM) the growthof a range
of clinical isolates of extended-spectrumβ-lactamase (ESBL)-producing
Escherichia coli and Klebsiella pneumoniae as well as a group of
miscellaneous ESBL-producing strains (Citrobacter, Salmonella, Serra-
tia, Shigella spp.) [21]. Unexpectedly, ESBL-producing Proteus mirabilis
strains were susceptible to ascaphin-8 (MIC=12.5–25 μM) although
non-ESBL isolates of this organism were resistant (MICN100 μM). The
therapeutic potential of ascaphin-8, especially for systemic application,
is limited by toxicity against mammalian cells (LC50 against human
erythrocytes=55 μM). Analogs containing amino acid substitutions at
Ala10, Val14, and Leu18 in ascaphin-8 by either L-Lys or D-Lys display
increased cationicity while maintaining amphipathicity and these
peptides retain antimicrobial activity against Gram-negative and
Gram-positive bacteria and against the opportunistic yeast pathogen,Fig. 1. A comparison of the primary structures of peptides belonging to the ascaphin
family from A. truei (coastal range) and from A. montanus (inland range, designated M).
(−) denotes those amino acids that are conserved in the peptides.Candida albicans but showed appreciably reduced toxicities (N10-fold)
against human erythrocytes, HepG2 hepatoma-derived cells, and L929
ﬁbroblasts [22].
4. Antimicrobial peptides from North American frogs of the
Ranidae family
4.1. Distribution and molecular heterogeneity
Skin secretions of North American ranid frogs produce a diverse
array of antimicrobial peptides that may be grouped together in
families on the basis of limited structural similarity. The degree of
molecular heterogeneity among peptides within a particular family is
appreciable with a peptide from one species rarely being found with
an identical amino acid sequence in another, even when species are
quite closely related to each other phylogenetically. Nucleotide
sequence analysis of cDNAs encoding the biosynthetic precursors of
these peptides has shown that the structural organization of the
precursors is quite similar, comprising a signal peptide sequence, an
acidic N-terminal spacer peptide region, and the antimicrobial peptide
at the C-terminus of the precursor [17]. Despite the fact that the
primary structures of antimicrobial peptides from the various families
show very little similarity to each other, the amino acid sequences of
the signal peptide and acidic pro-region have been remarkably well
conserved in the different precursors. It was proposed, therefore, that
the families share a common evolutionary origin having arisen from
multiple duplications of an ancestral gene during radiation of the
species, and within individual species [23]. This conclusion is
supported by identiﬁcation of multiple copies of genes encoding
antimicrobial peptides of the brevinin-1 family in the genomes of
individual specimens of the leopard frogs L. pipiens, L. chiricahuensis,
and L. sphenocephalus [24]. Allelic variation is low compared with
inter-species divergence and an excess of nonsynonymous substitu-
tions in the antimicrobial peptide coding region is indicative of po-
sitive natural selection.
At this time, at least 13well-established peptide families have been
identiﬁed in the skins of ranid frogs and may be listed as brevinin-1,
brevinin-2, esculentin-1, esculentin-2, japonicin-1, japonicin-2, nigro-
cin-2, palustrin-1, palustrin-2, ranacyclin, ranatuerin-1, ranatuerin-2,
and temporin (Table 1) [6]. Those families containing members that
have been isolated from North American species are underlined.
However, there are no well-deﬁned amino acid motifs that determine
antimicrobial activity so that unambiguous assignment of a newly
identiﬁed peptide to a particularly family can be difﬁcult or somewhat
arbitrary. Unfortunately, peptides fromvarious species that show clear
structural similarity to each other, indicative of a common evolu-
tionary origin, are often given completely different names by the
investigator who ﬁrst identiﬁed them so that there is a clear need for a
universally accepted terminology [10].
As well as a source of compounds with therapeutic potential, the
amino acid sequences of antimicrobial peptides in skin secretions may
be used to infer taxonomic and phylogenetic relationships between
species of ranid frogs [6]. For example, analysis of the distribution and
primary structures of dermal peptides from the Northern red-legged
frog [25] and the California red-legged frog [26] provides support for
the proposal that these anurans should be regarded as separate
species (R. aurora and R. draytonii) rather than conspeciﬁc subspecies
(Rana aurora aurora and Rana aurora draytonii). Similar analysis of the
structures of antimicrobial peptides from the N. American bullfrogs
(Aquarana) indicates a sister-group relationship between L. heckscheri
and L. grylio and a close, but less well deﬁned, phylogenetic
relationship between L. okaloosae and L. clamitans [27]. In general,
cladograms based upon the amino acid sequences of antimicrobial
peptides show a moderate to high degree of consistency with those
based upon comparisons of the nucleotide sequences of mitochondrial
and ribosomal genes [28,29].
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As shown in Table 1, peptides of the brevinin-1 family, ﬁrst
identiﬁed in the skin of the Asian frog R. brevipoda porsa [30] (now
reclassiﬁed as Pelophylax porosus), are very widely distributed among
the North American ranids having been detected in skin secretions
and/or skin extracts of all species investigated to-date except for R.
muscosa [31]. The inability to detect brevinin-1 peptides in this
species does not necessary mean that the gene is not expressed as it
is possible that a peptide with low antimicrobial potency would be
missed. The problem of assigning peptides to particular family is well
illustrated by the relationship between brevinin-1 and ranalexin.
Ranalexin was ﬁrst isolated from an extract of whole L. catesbeianus
tadpoles [32] and its distribution is restricted to those North
American species formerly classiﬁed within the Aquarana species
group [8]. Up to this time, ranalexin peptides have never been
detected in the skins of ranid frogs from other species groups and soFig. 2. Primary structures of peptides of the brevinin-1 family isolated from species of
North American frogs belonging to the genera Rana and Lithobates. Those sequences
underlined were originally designated ranalexins. (⁎) denotes deletion of an amino acid
residue from a putative ancestral peptide.
Fig. 3. A phylogenetic tree based upon the amino acid sequences of the brevinin-1
peptides isolated fromthe skins ofNorthAmerican frogs that are shown in Fig. 2. Cladistic
analysis was performed using the Phylogeny Inference Program package, PHYLIP, version
3,57c (J. Felsenstein, University ofWashington, SeattleWA,1993). The stability of the tree
was tested by bootstrap resampling analysis of 1000 replicates computed with the
SEQBOOT program. Genetic distances between each pair of amino acid sequences were
calculated using the PROTDIST program based on the categories model according to
chemical categorization of amino acids. From the corresponding distance matrix, the
phylogenetic tree was generated by the neighbor-joining method of the NEIGHBOR
program and displayed byDRAWGRAM. The amino acid sequence of brevinin-1 from the
Asian frog P. porosus (FLPVLAGIAAKVVPALFCKITKKC) was used as outgroup.the question arises as to whether ranalexin is encoded by a separate
gene that arose relatively late in evolution within the common
ancestor of the Aquarana or whether it represents an ortholog of
another more widely distributed antimicrobial peptide. As shown in
Fig. 2, the amino sequences of the ranalexins show strong structural
similarity to members of the brevinin-1 family from other North
American species including the presence of the strongly conserved
Phe1, Lys11, Pro14, Cys18, Lys22, Lys23, and Cys24 residues. Structural
similarity is maximized if it is assumed that the genes encoding the
ranalexins have undergone a deletion of a region encoding a
contiguous tetrapeptide. Consequently, the term “ranalexin” becomes
superﬂuous and should no longer be used. It is signiﬁcant that the
skin of a seventh member of the Aquarana species group, L.
septentrionalis contains brevinin-1 peptides from which a different
tetrapeptide has been deleted (Fig. 2) [33]. By the same token,
molecular cloning studies have demonstrated that the melittin-
related peptides found in the skin of Rana draytonii and in the skins
of certain Japanese brown frogs and are not evolutionarily related to
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assigned to the brevinin-1 family [34].
Previous studies involving ranid frogs have shown that that the
amino acid sequences of brevinin-1 peptides in skin secretionsmay be
used to complement other molecular analyses, such as comparison of
nucleotide sequence of mitochondrial genes, in elucidating phyloge-
netic and evolutionary relationships between species [5,35]. A
neighbor-joining analysis based upon the amino acid sequences of
the known brevinin-1 peptides isolated from North American frogs
(Fig. 3) provides strong support for assignment of species into the two
genera Rana and Lithobates. All species in the genus Rana, formerly
classiﬁed in the Amerana group [8,28], segregate together in a single
clade denoted by the box in Fig. 3 that is distinct from the clade
containing the species in the genus Lithobates. Placement of the
ranalexin sequences from bullfrogs formerly classiﬁed within the
Aquarana species group [8,29] within a larger clade containing
brevinin-1 sequences supports the assertion that the ranalexins
represent brevinin-1 peptides that have undergone a four amino
acid residue internal deletion (Fig. 2).
Among the brevinin-1 peptides isolated from North American
species, brevinin-1BYa from the foothill yellow-legged frog R. boylii
has been themost extensively studied [36]. A synthetic replicate of the
peptide showed growth inhibitory activity (minimum inhibitory
concentration MIC≤10 μM) against a range of reference strains of
Gram-positive and Gram-negative bacteria, including EnterobacterFig. 4. Primary structures of peptides of the ranatuerin-2 family isolated from species of Nort
amino acid residue.cloacae, Pseudomonas aeruginosa, Staphylococcus epidermidis, Entero-
coccus faecalis, and Streptococcus group B, against clinical isolates of
methicillin-resistant Staphylococcus aureus (MRSA) (MIC=2.5 μM),
and against reference strains and clinical isolates of the opportunistic
yeast pathogens C. albicans, C. tropicalis, C. krusei, and C. parapsilosis
(MIC≤10 μM). However, the therapeutic potential of the peptide,
especially for systemic applications, is restricted by its high hemolytic
activity against human erythrocytes (LD50=10 μM). Replacement of
the cysteine residues in brevinin-1BYa by serine produced an acyclic
analog with eight-fold reduced hemolytic activity that retained high
potency against Gram-positive bacteria, including strains of MRSA
(MIC=5 μM) suggesting that the peptide represents a candidate for
drug development, particularly for topical applications against
antibiotic-resistant microorganisms. The broad-spectrum antimicro-
bial activity of “ranalexin” is similar to that of members of the
brevinin-1 family [6].
4.3. Ranatuerin-2 peptides
Members of the ranatuerin-2 family of peptides, ﬁrst identiﬁed in
the skin of the bullfrog L. catesbeianus [37], are present in skin
secretions of most species of ranid frogs of North American origin
studied to-date (Table 1). The family has amore restricted distribution
in Eurasian species [6]. A C-terminal cyclic hexapeptide domain, rather
than the more common heptapeptide, characterizes the peptide. Itsh American frogs belonging to the genera Rana and Lithobates. (⁎) denotes deletion of an
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North American frogs with several residue deletions and only the
cysteine residues invariant (Fig. 4). Ranatuerin-2 is also a peptide
whose amino acid sequence has been used in phylogenetic analyses to
infer evolutionary relationships between species [6,27,38]. As shown
in Fig. 5, a neighbor-joining analysis based upon the amino acid
sequences of the known ranatuerin-2 peptides isolated from North
American frogs (Fig. 4) provides some support for the division of
species into Rana and Lithobates but evidence is less convincing than
in the case of brevinin-1 (Fig. 3). Ranatuerin-2 peptides from
frogs from the genus Rana segregate with a single clade, denoted
by the box in Fig. 5, but embedded within this clade are sequences
from L. palustris and L. tarahumarae. Similarly, the well deﬁned
clade containing all the sequences from the Lithobates species
formerly classiﬁed in the Aquarana group also contains a sequence
from L. berlandieri.
The marked variation in the amino acid sequence of ranatuerin-2
is matched by a correspondingly wide variability in observed
antimicrobial speciﬁcities and potencies and in hemolytic activities
[6]. The potent broad-spectrum antimicrobial activity but relatively
weak hemolytic activity of ranatuerin-2CSa, ﬁrst isolated from skin
secretions of the Cascades frog, Rana cascadae [38], suggests that
the peptide may have the potential for antibacterial drug develop-
ment. The solution structure of ranatuerin-2CSa has been investi-
gated by proton NMR spectroscopy and molecular modelling [39]. InFig. 5. A phylogenetic tree based upon the amino acid sequences of the ranatuerin-2
peptides isolated from the skins of North American frogs that are shown in Fig. 4.
Cladistic analysis was carried out as described in the legend to Fig. 3. The amino acid
sequence of ranatuerin-2 from the Asian frog R. sakuraii (GLLDAIKDTAQNLFAN
VLDKIKCKFTKC) was used as outgroup.
Fig. 6. Primary structures of peptides of the temporin family isolated from species
of North American frogs belonging to the genera Rana and Lithobates. All peptides are
C-terminally α-amidated.aqueous solution, the peptide lacks secondary structure but, in a
triﬂuoroethanol–water solvent mixture, the peptide adopts a stable
conformation that is characterized by a full length helix-turn-helix
motif between residues Ile2-Leu21, Leu22-Leu25 and Lys26-Thr30
respectively.
4.4. Temporin peptides
Peptides of the temporin family are widely distributed among
species of Eurasian and New World ranids and approaching 100
different members of the family have been identiﬁed to-date [40]. The
primary structures of those temporins isolated from North American
frogs are shown in Fig. 6. Because of their small size (10–21 amino
acid residues) and ease of synthesis, the temporins have received
attention as lead compounds for development into therapeutically
valuable anti-infective agents [41]. Among the temporin peptides from
Fig. 7. A comparison of the primary structures of peptides related to ranacyclin and
brevinin-2 isolated from the skins of ranid frogs. The shaded residues are conserved.
Residue deletions denoted by (⁎) have been introduced in some sequences to maximize
structural similarity.
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isolated from norepinephrine-stimulated skin secretions of the
California red-legged frog R. draytonii [26], and temporin-Va from
the carpenter frog, L. virgatipes [42] have been studied in most detail.
Unlike many of the more hydrophobic members of the family eg
temporin-Vc, these peptides are very soluble in aqueous media. Most
temporins showgrowth-inhibitory activity only against Gram-positive
bacteria but temporin-DRa and temporin-Va are atypical in displaying
activity against reference strains of several clinically relevant Gram-
negative species (E. coli, K. pneumoniae, E. cloacae. P. aeruginosa,
Salmonella typhimurium) and against the opportunistic yeast pathogen
C. albicans as well as multidrug-resistant strains of S. aureus (MRSA)
[43]. In addition to broad-spectrum activity against aerobic bacteria,
temporin-DRa and temporin-Va show high potency (MIC≤12.5 μM)
against reference strains and clinical isolates of the Gram-positive
anaerobes Propionibacterium acnes and Clostridium tertium and were
active (MIC≤50 μM) against the Gram-positive cocci Poststreptococcus
asacharolyticus and Poststreptococcus anaerobius and the Gram-
negative bacillus Provotella melaninogenica [43].
The therapeutic potential of temporin-DRa is restricted by its signi-
ﬁcant hemolytic activity against human erythrocytes (LD50=70 μM).
A structure-activity study has demonstrated that analogs containing
the substitutions (Val7→ L-Lys), (Thr5→ D-Lys) and (Asn8→ D-Lys)
retained the high solubility and potent, broad spectrum antimicrobial
activity of the naturally occurring peptide but were appreciably (up to
10-fold) less hemolytic [44]. Similarly, substitution of Ile13 by
α-aminoisobutyric acid (Aib) produces a 4-fold increase in therapeu-
tic index (ratio of LC50 against erythrocytes to MIC against micro-
organisms) [45], identifying these peptides as compound with
potential for development as anti-infective agents. The data suggest
a strategy that involves selective increases in cationicity that maintain
amphipathicity but increase Φ (the angle subtended by the charged
residues) in order to transform naturally-occurring temporins into
non-toxic analogs with therapeutic utility. Increases in hydrophobicity
and helicity generally increase cytolytic activity against mammalian
cells. This conclusion is consistent with several studies involving other
naturally occurring and synthetic antimicrobial peptides (reviewed in
[44]).
In addition to their abilities to inhibit growth of microorganisms,
temporin-Vb from L. virgatipes [42] and temporin-DRb from
R. draytonii [26], in the concentration range 10−8–10−6 M, produced
signiﬁcant (pb0.05) and dose-dependent stimulatory effects on
insulin secretion from clonal rat BRIN-BD11 insulinoma-derived cells
[46]. This increase in the rate of insulin releasewas not associatedwith
an increased release of lactate dehydrogenase indicating that the
integrity of the plasma membrane was maintained. The observation
raises the possibility that the peptides may be developed into agents
with therapeutic potential for treatment of patients with Type 2
diabetes.
4.5. Ranacyclin-related peptides
The term ranacyclin was ﬁrst used to describe two 17-amino acid
residue peptides with antibacterial and antifungal activities synthe-
sized in the skins of the Eurasian frogs R. temporaria (ranacyclin T) and
R. esculenta (now reclassiﬁed as a hybridogenetic complex between
Pelophylax lessonae and P. ridibundus) (ranacyclin E) [47]. A comparison
of their primary structures reveals a high degree of sequence identity
with peptides previously identiﬁed in skin secretions of the North
American frogs L. pipiens (termed peptide LR) [48] and L. palustris [49],
and limited similarity with peptides from R. aerolata [50] suggesting
that the ranacyclins constitute a peptide family with a common origin
(Fig. 7). Ranacyclins E and Tand peptide LR are exceptional among frog
skin antimicrobial peptides in that theyadopt a predominantly random
coil conformation even in a membrane-mimetic solvent such as 1%
sodium dodecylsulfate solution, as demonstrated by CD and FourierTransform Infrared (FTIR) spectroscopy. The ranacyclins bind and
insert into both zwitterionic (phosphatidylcholine/cholesterol) and
negatively charged (phosphatidylglycerol/phosphatidyletha-
nolamine) model membrane vesicles suggesting that the primary
interaction is with the hydrophobic core of the cell membrane rather
than the more usual electrostatic interaction of the peptide with the
lipid head group. A two-step mode of action was proposed with the
peptidesﬁrst aligning parallel to the outermembrane surface boundby
predominantly hydrophobic interactions and subsequently, at higher
peptide concentrations, inserting into the hydrophobic core of the
membrane bilayer to form transmembrane pores [47].
4.6. Brevinin-2-related peptides
Brevinin-2 was ﬁrst isolated from the skin of the Japanese frog
P. porosus [30] and subsequent work has shown that members of
the family are widely distributed in Eurasian species but to-date
brevinin-2 peptides have not been detected in any North American
ranid. However, structurally-related C-terminally α-amidated pep-
tides were isolated from skin secretions from L. virgatipes [42] and L.
septentrionalis [33] that show sequence similarity to peptides
belonging to the brevinin-2 family but lack the C-terminal cyclic
heptapeptide domain Cys-Lys-Xaa4-Cys, that is present in orthologs
from other species (Fig. 7). Such truncated forms of brevinin-2 were
not identiﬁed in the skins of other frogs belonging to the Aquarana
species group. This observation provides further support for a close
phylogenetic relationship between L. virgatipes and L. septentrionalis
[26,28]. The relatively high potency of the peptide from L. septen-
trionalis (MIC≤25 μM) against Gram-positive (S. aureus) and Gram-
negative (E. coli) bacteria and against the opportunistic yeast
pathogen (C. albicans) demonstrates that the cyclic domain in
brevinin-2 is not necessary for antimicrobial activity.
Antimicrobial activity of frog skin peptides is almost always
determined using reference strains or clinical isolates of microorga-
nisms that are relevant to human disease rather than against those
that the animal might encounter in the wild. However, the brevinin-2
related peptide from L. septentrionalis inhibited growth of isolates of
the genera Pseudomonas, Serratia, Bacillus, Aeromonas, Burkholderia,
Microbacterium, and Delftia that were obtained from the frog's natural
habitat [3].
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